GlassScriptPhysician profile
Dawn Gutierrez
NPI 1386285260
$3,409.65
in general payments reported to CMS, 2019-2025
8 companies · $762 in 2025
The $762 reported for 2025 was more than what 75% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $464 · 2022: $816 · 2023: $508 · 2024: $860 · 2025: $762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,129.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,795.10 | 2021-2025 | Descovy, Yeztugo |
| Viiv Healthcare Company | $1,042.58 | 2021-2025 | Dovato, Apretude |
| Merck Sharp & Dohme LLC | $270.79 | 2023-2025 | Pifeltro, Delstrigo |
| Janssen Products, LP | $99.99 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $74.73 | 2024-2025 | Caplyta |
| Janssen Biotech, INC. | $74.14 | 2021-2023 | Symtuza |
| Lundbeck LLC | $27.48 | 2024 | Rexulti |
| Vanda Pharmaceuticals INC. | $24.84 | 2025 | Fanapt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Gutierrez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.